arket and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts
, PAREXEL operates in 74 locations throughout 51 countries around the world, and has approximately 14,000 employees. For more information about PAREXEL International visit www.PAREXEL.com
PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.
This release contains "forward-looking" statements regarding future results and events, including, without limitation, statements regarding the Company's intention to repurchase shares of its common stock from time to time under the stock repurchase program, the timing and amounts of any repurchases, the intended use of any repurchased shares, the source of funding for the stock repurchase program, and the Company's expected financial results, future growth and customer demand. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "will," "would," "could," "should," "targets," and similar expressions are also intended to identify forward-looking statements.
Page: 1 2 3 4 Related medicine technology :1
|SOURCE PAREXEL International Corporation|
Copyright©2012 PR Newswire.
All rights reserved
. PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference2
. PAREXEL International To Present At Citi Global Healthcare Conference3
. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results4
. PAREXEL International To Present At Oppenheimer Healthcare Conference5
. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference6
. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program7
. PAREXEL International to Present at Robert Baird Healthcare Conference8
. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals9
. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies10
. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization11
. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call